COST CM1407
Challenging organic synthesis inspired by nature - from natural products to drug discovery |
|
Program: |
COST |
MC member: |
|
Duration: |
15.3.2015 - 14.3.2019 |
COST CA15135 MuTaLig - Multi-target paradigm for innovative ligand identification in the drug discovery process |
|
Program: |
COST |
MC member: |
|
Duration: |
4.12.2015 - 29.10.2019 |
GLUCOLIPOTOX - Targeting Molecular Pathways of Glucolipotoxicity by a Novel Carboxymethylated Mercaptotriazinoindole Inhibitor of Aldo-Keto Reductase AKR1B1 In Diabetes, Inflammation and Age-related Neurodegeneration |
|
|
|
Program: |
Bilateral SAS-Tübitak |
MC member: |
|
Duration: |
1.5.2016-30.4.2019 |
National projects
Pharmacological intervention in glucose-toxicity in type 2 diabetes |
|
Program: |
APVV |
Project leader: |
|
Duration: |
01.07.2016 - 30.06.2020 |
Indole-1-acetic acid derivatives as aldose reductase inhibitors: structure – activity relationships |
|
Program: |
VEGA |
Project leader: |
|
Duration: |
1.1.2018 - 31.12.2021 |
Novel compounds in prevention and treatment of diseases caused by glucose toxicity |
|
Program: |
VEGA |
Project leader: |
|
Duration: |
1.1.2018 - 31.12.2021 |
Modulation of calcium homeostasis in pancreatic ß-cells by flavonoids under conditions of endoplasmic reticulum stress |
|
Program: |
VEGA |
Project leader: |
|
Duration: |
1.1.2016 - 31.12.2018 |